Expertise Term: target of rapamycin (TOR)
 NameInstitutionRole
Toker, AlexBeth Israel Deaconess Medical CenterEditor-in-Chief
 
 
Name: Toker, Alex
Role: Editor-in-Chief
Email: atoker@asbmb.org
Institution: Beth Israel Deaconess Medical Center
Department: Pathology
Subject Categories:
Expertise Terms: cell signaling, mTOR complex (mTORC), oncogene, phosphatase and tensin homolog (PTEN), phosphatidylinositide 3-kinase (PI 3-kinase), phosphatidylinositol signaling, phosphotyrosine signaling, protein kinase, signal transduction, target of rapamycin (TOR)
Du, WeiThe University of ChicagoEditorial Board Member
 
 
Name: Du, Wei
Role: Editorial Board Member
Email: wei@uchicago.edu
Institution: The University of Chicago
Department: Ben May Department for Cancer Research
Subject Categories:
Expertise Terms: beta-catenin (B-catenin ), cell cycle, cell death, cyclin-dependent kinase (CDK), drosophila genetics, E2F transcription factor, p53, retinoblastoma protein (pRb, RB), target of rapamycin (TOR), tuberous sclerosis complex (TSC)
Ramesh, VijayaMassachusetts General HospitalEditorial Board Member
 
 
Name: Ramesh, Vijaya
Role: Editorial Board Member
Email: ramesh@helix.mgh.harvard.edu
Institution: Massachusetts General Hospital
Department: Center for Genomic Medicine
Subject Categories:
Expertise Terms: cell signaling, genetic disease, mammalian target of rapamycin (mTOR), molecular bases of disease, mTOR complex (mTORC), S6 kinase, signal transduction, target of rapamycin (TOR), TOR complex (TORC), tuberous sclerosis complex (TSC)